4//SEC Filing
Reynolds Thomas C 4
Accession 0001203311-13-000008
CIK 0001060736other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 8:16 PM ET
Size
23.6 KB
Accession
0001203311-13-000008
Insider Transaction Report
Form 4
Reynolds Thomas C
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2013-01-28$12.16/sh+1,027$12,488→ 58,628 total - Exercise/Conversion
Common Stock
2013-01-28$12.00/sh+2,604$31,248→ 60,205 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2013-01-28−1,027→ 7,196 totalExercise: $12.16Exp: 2019-08-25→ Common Stock (1,027 underlying) - Sale
Common Stock
2013-01-28$30.19/sh−2,604$78,609→ 57,601 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-01-28−2,604→ 41,147 totalExercise: $12.00Exp: 2020-08-27→ Common Stock (2,604 underlying) - Sale
Common Stock
2013-01-25$29.84/sh−2,083$62,155→ 57,601 total - Sale
Common Stock
2013-01-28$30.19/sh−1,027$31,003→ 57,601 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-01-25−2,083→ 58,116 totalExercise: $15.46Exp: 2021-08-24→ Common Stock (2,083 underlying) - Exercise/Conversion
Common Stock
2013-01-25$15.46/sh+2,083$32,203→ 59,684 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-01-28−1,576→ 11,035 totalExercise: $12.16Exp: 2019-08-25→ Common Stock (1,576 underlying) - Sale
Common Stock
2013-01-28$30.19/sh−1,576$47,576→ 57,601 total - Exercise/Conversion
Common Stock
2013-01-28$12.16/sh+1,576$19,164→ 59,177 total
Footnotes (7)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Reynolds on December 13, 2012.
- [F2]$29.8393 represents an average price per share for the shares sold on 1/25/2013. The sell price for shares sold on this day ranged from $29.69 to $29.90.
- [F3]Amount of securities beneficially owned following reported transactions includes 53,886 Restricted Stock Units subject to vesting.
- [F4]$30.1878 represents an average price per share for the shares sold on 1/28/2013. The sell price for shares sold on this day ranged from $30.10 to $30.25.
- [F5]Shares shall vest at a rate of 25% on 8/25/10 and monthly thereafter until all the shares are fully vested on 8/25/13.
- [F6]Shares shall vest at a rate of 25% on 8/27/11 and monthly thereafter until all the shares are fully vested on 8/27/14.
- [F7]Shares shall vest at a rate of 25% on 8/24/12 and monthly thereafter until all the shares are fully vested on 8/24/15.
Documents
Issuer
SEATTLE GENETICS INC /WA
CIK 0001060736
Entity typeother
Related Parties
1- filerCIK 0001393945
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 8:16 PM ET
- Size
- 23.6 KB